1Department of PharmacoEpidemiology & PharmacoEconomics, University of Groningen , Groningen , The Netherlands.
COPD. 2013 Dec;10(6):629-39. doi: 10.3109/15412555.2013.813446. Epub 2013 Jul 11.
To explore the full economic impact, on both patients and government, as a result of COPD in the working age population.
The economic impact of COPD due to medical treatment, impaired productivity and early retirement was assessed in a cross sectional cost analysis of the Dutch COPD population aged 45-64 years. The costing year was 2009 and input parameters were derived from both national data sources and the international COPD uncovered survey.
While direct medical costs for COPD patients of working age were relatively low (€ 91 million), the amount of lost productivity (income) due to early retirement (€ 223 million) exceeded over two times their medical costs. In addition, costs for the government were considerable because of lost tax revenues (€ 77 million) and COPD related disability pensions paid (€ 180 million). Apart from lost productivity due to early retirement, costs due to impaired productivity for working COPD patients were € 63 million.
The costs of COPD for both patients of working age as for the government were considerable, making this population a priority for prevention and intervention programs of healthcare providers, employers and government.
探讨在工作年龄人群中，COPD 给患者和政府带来的全部经济影响。
采用横断面成本分析方法，评估了 45-64 岁荷兰 COPD 人群的医疗费用、生产力受损和提前退休导致的经济影响。成本核算年度为 2009 年，投入参数来自国家数据来源和国际 COPD 未覆盖调查。
虽然工作年龄 COPD 患者的直接医疗费用相对较低（9100 万欧元），但由于提前退休（2.23 亿欧元）导致的生产力损失（收入）超过了医疗费用的两倍。此外，由于税收损失（7700 万欧元）和支付的 COPD 相关残疾养恤金（1.8 亿欧元），政府的支出也相当可观。除了提前退休导致的生产力损失外，工作中 COPD 患者的生产力受损导致的成本为 6300 万欧元。
工作年龄患者和政府的 COPD 成本相当可观，这使得该人群成为医疗保健提供者、雇主和政府预防和干预计划的重点。
